Celltrion
068270.KS
#676
Rank
S$47.35 B
Marketcap
S$216.44
Share price
-1.61%
Change (1 day)
35.44%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): S$2.46

According to Celltrion 's latest financial reports the company's current EPS (TTM) is S$2.39. In 2024 the company made an earnings per share (EPS) of S$1.70 a decrease over its 2023 EPS that were of S$3.36.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$2.4644.88%
2024S$1.70-49.57%
2023S$3.36-2.08%
2022S$3.43-11.72%
2021S$3.892.03%
2020S$3.8182.8%
2019S$2.0918.31%
2018S$1.76-36.33%
2017S$2.77161.25%
2016S$1.062.86%
2015S$1.0317.84%
2014S$0.875.87%
2013S$0.83-70.85%
2012S$2.83134.09%
2011S$1.2143.59%
2010S$0.8474.49%
2009S$0.48317.8%
2008S$0.12-71.7%
2007S$0.41